1. Damier P, Hirsch EC, Agid Y, Graybiel AM (1999) The substantia nigra of the human brain. II Patterns of loss of dopamine-containing neurons in Parkinson's disease Brain 122:1437–1448
2. Heinz A, Przuntek H, Winterer G, Pietzcker A (1995) Clinical aspects and follow-up of dopamine-induced psychoses in continuous dopaminergic therapy and their implications for the dopamine hypothesis of schizophrenic symptoms. Nervenarzt 66:662–669
3. Ciszewski A, Milczarek G (1999) Polyeugenol-modified platinum electrode for selective detection of dopamine in the presence of ascorbic acid. Anal Chem 71:1055–1061
4. Martin C (1998) The Parkinson’s puzzle, new developments in our understanding of Parkinson’s disease have generated a number of promising new treatments for this disabling condition. Chem Br 34:40–42
5. Wightman RM, May LJ, Michael AC (1988) Detection of dopamine dynamics in the brain. Anal Chem 60:769A–779A